TITLE

REMINYL ALZHEIMER'S TREATMENT GETS FIRST EU APPROVAL

PUB. DATE
April 2000
SOURCE
Worldwide Biotech;Apr2000, Vol. 12 Issue 4, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Reminyl or galantine, a symptomatic treatment for dementia of the Alzheimer's type, has received regulatory approval from the European Union.
ACCESSION #
3004625

 

Related Articles

  • Product News. Once-Daily Formulation of Alzheimer's Drug Receives Approval.  // Journal of Gerontological Nursing;Aug2010, Vol. 36 Issue 8, p9 

    The author reports that the U.S. Food and Drug Administration has approved Namenda XR (memantine hydrochloride) for the treatment of moderate severe dementia of the Alzheimer's type.

  • R&D Projects Target Mental Illness.  // Chain Drug Review;8/30/2010, Vol. 32 Issue 14, p106 

    The article reports on a study issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) which claims that about 60 million Americans have mental health problems and medications in development are intended for treating dementia.

  • Generic Forms of Aricept Win Approval From FDA.  // Chain Drug Review;1/18/2010, Vol. 32 Issue 2, p38 

    The article reports on the approval of the first generic versions of Aricept or donepezil hydrochloride orally disintegrating tablets, indicated for the treatment of dementia related to Alzheimer's disease by the U.S. Food and Drug Administration.

  • Clinical and Economic Factors in the Treatment of Behavioural and Psychological Symptoms of Dementia. Hemels, M.E.; Lanctot, K.L.; Iskedjian, M.; Einarson, T.R. // Drugs & Aging;2001, Vol. 18 Issue 7, p527 

    The prevalence of behavioural and psychological symptoms of dementia (BPSD) exceeds 50%. They cause distress to patients and caregivers, increase resource utilisation of various kinds, and form a high risk for accelerated psychiatric care through institutionalisation. Although evidence for...

  • AKT answer relating to drugs used for dementia.  // InnovAiT;Aug2011, Vol. 4 Issue 8, p483 

    The article presents an answer regarding the drugs used for dementia provided by the Advanced Knowledge Technologies (AKT).

  • AKT question relating to drugs used for dementia. Rajput, Ranbir // InnovAiT;Aug2011, Vol. 4 Issue 8, p457 

    A quiz concerning drugs that are used for severe dementia in Alzheimer's disease is presented.

  • TJ 54.  // Reactions Weekly;10/6/2012, Issue 1422, p47 

    The article describes the case of a woman who developed pseuodoaldosteronism during treatment with TJ 54 for the behavioral and psychological symptoms of dementia.

  • Rivastigrnine.  // Reactions Weekly;11/3/2012, Issue 1426, p39 

    The article describes the case of a 79-year-old Taiwanese man who developed mania during treatment with rivastigmine for Alzheimer-type dementia.

  • Progress in antipsychotic reduction.  // Nursing & Residential Care;Sep2013, Vol. 15 Issue 9, p589 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics